Frontida BioPharm Fined for Years of Hazardous Waste Violations
EPA found the Philadelphia pharmaceutical packager operated without permits, skipped inspections for three years, and mishandled toxic waste including mercury lamps and ignitable chemicals.
Frontida BioPharm, a Philadelphia pharmaceutical packager owned by Adare Pharma Solutions since 2021, violated federal hazardous waste laws for years. The EPA found the company operated a hazardous waste storage facility without a permit, failed to conduct required weekly inspections for three years, improperly managed toxic materials including mercury-containing lamps and ignitable chemicals, and shipped hazardous waste without proper documentation. The company agreed to pay a $13,750 penalty and certified it corrected the violations.
This case shows how pharmaceutical companies can quietly violate environmental protections for years before detection.
The Allegations: A Breakdown
| 01 | Frontida BioPharm operated a hazardous waste storage facility without a permit. On March 1, 2023, the company accepted hazardous waste from its Orthodox facility, which is a Large Quantity Generator. Regulations only allow Very Small Quantity Generators to consolidate waste at Large Quantity Generator sites under specific conditions, not Small Quantity Generators like Frontida. | high |
| 02 | The company failed to conduct weekly inspections of its hazardous waste accumulation area for three years, from March 1, 2020 to at least March 1, 2023. These inspections are required by federal regulations incorporated into Pennsylvania law to detect leaking containers and prevent environmental releases. | high |
| 03 | Frontida failed to make waste determinations at the point of generation for multiple waste streams. The EPA inspector observed approximately 200 rejected material containers in the Reject Cage without hazardous waste determinations. Facility representatives stated rejected material accumulates for an unspecified period before any determination is made. | high |
| 04 | The company mismanaged waste aerosol cans, with facility representatives admitting they were unsure how waste aerosol cans are managed and how previously generated waste aerosol cans had been disposed. The inspector observed in-use aerosol cans at the facility with no documented disposal procedures. | medium |
| 05 | Frontida disposed of IPA-contaminated wipes as nonhazardous waste without providing any hazardous waste determination documentation. At the time of inspection, facility representatives stated these wipes are disposed as nonhazardous waste without proper characterization. | medium |
| 06 | The company failed to file an exception report after 45 days when a designated facility did not sign manifest 024947115JJK for a shipment of D001 hazardous waste on May 17, 2023. There is no record of the required exception report being filed on July 2, 2023. | medium |
| 07 | From March 1, 2020 to at least March 1, 2023, Frontida shipped hazardous waste from the facility to its Orthodox facility without documenting the shipments on Uniform Hazardous Waste Manifests. Facility representatives stated hazardous waste was shipped between facilities without manifest documentation during this entire three-year period. | high |
| 08 | The EPA inspector observed six open containers of universal waste lamps containing mercury, which increases the risk of breakage and mercury release. Mercury is a potent neurotoxin that poses serious health risks. | high |
| 01 | Violations persisted for three years before EPA detection. The company failed to conduct weekly inspections and failed to document hazardous waste shipments from March 1, 2020 to at least March 1, 2023, demonstrating a prolonged period of undetected non-compliance. | high |
| 02 | The EPA did not conduct a compliance evaluation inspection at the facility until March 1, 2023, allowing years of violations to continue undetected. The gap between violations beginning in 2020 and inspection in 2023 reveals limitations in regulatory oversight frequency. | medium |
| 03 | Pennsylvania’s state environmental agency, PADEP, received notice of the enforcement action on October 24, 2024, more than a year and a half after the inspection. This extended timeline delayed state-level awareness and potential additional oversight. | medium |
| 04 | The settlement was reached through an expedited process that allowed the company to neither admit nor deny the specific factual allegations. Only jurisdictional allegations were admitted, meaning no formal admission of the environmental lapses occurred. | medium |
| 05 | No individual executives or managers faced personal liability for the operational decisions that led to years of violations. The settlement only named Frontida BioPharm, LLC as the corporate entity, with no accountability for individuals responsible. | medium |
| 06 | The EPA based its enforcement on regulations from 2005, which were the last revisions Pennsylvania incorporated by reference on June 29, 2009. This means the state’s hazardous waste program may not reflect nearly two decades of updated federal standards. | low |
| 01 | Operating without a permit for storing waste from another facility allowed Frontida to avoid significant costs. Establishing and maintaining a permitted hazardous waste storage facility involves expenses for infrastructure, training, and administrative oversight that the company circumvented. | high |
| 02 | Skipping weekly inspections for three years saved substantial labor costs. These inspections require dedicated staff time and meticulous record-keeping that the company avoided throughout the violation period. | high |
| 03 | Failing to properly characterize waste streams like Reject Cage Material and IPA-contaminated wipes reduced analytical and disposal costs. Hazardous waste disposal is typically more expensive than non-hazardous waste disposal, creating financial incentive to misclassify materials. | medium |
| 04 | The $13,750 penalty may be viewed as a minor cost of doing business when weighed against potential savings from years of non-compliance. For a commercial pharmaceutical packaging entity, this sum does not represent a significant financial deterrent against future violations. | high |
| 05 | Shipping hazardous waste between facilities without manifests avoided documentation costs and simplified operations. The company saved on administrative labor by bypassing the cradle-to-grave tracking system designed to ensure proper waste handling. | medium |
| 06 | Frontida BioPharm was acquired by Adare Pharma Solutions in 2021, during the period when violations were ongoing. The new ownership continued operations with existing compliance failures, suggesting inadequate due diligence or prioritization of environmental obligations during the acquisition. | medium |
| 01 | Six open containers of universal waste lamps containing mercury posed direct contamination risks. Mercury is a potent neurotoxin, and storing lamps in open containers increases the risk of breakage and mercury release into the environment. | high |
| 02 | The company stored hazardous wastes classified as D001 (ignitable), D002 (corrosive), and F003 (spent non-halogenated solvents like Isopropyl Alcohol). These materials can cause fires, chemical burns, and toxic exposures if not properly managed. | high |
| 03 | Three years without weekly inspections meant potential leaks, deteriorating containment, or other hazardous conditions could have gone unnoticed and unaddressed. Early detection of problems is critical to preventing releases into soil, water, or air. | high |
| 04 | Misclassifying hazardous waste as non-hazardous could have led to improper disposal in municipal landfills not designed to contain such materials. This creates risks of groundwater contamination and toxic emissions affecting surrounding communities. | high |
| 05 | Improperly managed batteries can leak heavy metals or corrosive materials. The inspector observed two unlabeled containers of universal waste batteries and containers without accumulation start dates, indicating inadequate tracking and containment. | medium |
| 06 | Waste aerosol cans were observed at the facility with no clear management procedures. Facility representatives admitted uncertainty about disposal methods, creating risks of pressurized container explosions or release of ignitable contents. | medium |
| 07 | The facility is located at 7722 Dungan Road in Philadelphia, placing these hazardous waste risks in an urban environment with nearby residential areas. Potential spills, fires, or releases could directly impact local community members. | high |
| 08 | Undocumented shipments of hazardous waste between facilities obscured the chain of custody and accountability. This lack of documentation made it impossible to verify that hazardous waste reached appropriate treatment, storage, or disposal facilities. | medium |
| 01 | The facility operates in Philadelphia at 7722 Dungan Road, placing hazardous waste management failures in an urban setting. Violations involving ignitable, corrosive, and mercury-containing wastes created risks for nearby residents and local ecosystems. | high |
| 02 | Three years of uninspected hazardous waste storage areas meant potential environmental releases could have affected local soil, groundwater, or air quality. Communities rely on proper industrial oversight to protect their living environment. | high |
| 03 | Improperly stored ignitable and corrosive wastes increased risks of fires, explosions, or dangerous chemical reactions. Such incidents could have affected not only the facility but also its immediate surroundings and emergency responders. | medium |
| 04 | The EPA reserves the right to act if it determines an imminent and substantial endangerment to public health, public welfare, or the environment. This language acknowledges that the violations created real risks to the surrounding community that may require future intervention. | medium |
| 01 | The $13,750 penalty for three years of violations may not serve as a meaningful deterrent. The fine amounts to roughly $4,583 per year of non-compliance, a sum that may be viewed as a minor business expense rather than a significant consequence. | high |
| 02 | Frontida BioPharm did not admit to the specific factual allegations as part of the settlement. The company only admitted jurisdictional facts, meaning no formal admission of wrongdoing regarding the environmental and safety lapses occurred. | medium |
| 03 | No individual executives, managers, or employees faced personal liability or penalties. The settlement only held the corporate entity accountable, allowing individuals responsible for operational decisions to avoid consequences. | high |
| 04 | The expedited settlement process prioritized efficiency over thorough public reckoning. While this approach secured compliance quickly, it avoided deeper examination of the corporate culture that allowed systematic violations to persist. | medium |
| 05 | The settlement allows the company to avoid federal tax deductions for the civil penalty. However, this provision does not address whether the penalty amount itself is sufficient to change behavior or deter future violations. | low |
| 06 | The agreement required Frontida to certify that violations have been corrected, focusing on future compliance rather than accountability for past harm. No assessment of environmental damage or community exposure during the violation period was documented. | medium |
| 01 | Violations occurred from March 1, 2020 to at least March 1, 2023 before EPA detection. This three-year period of undetected non-compliance allowed the company to benefit from avoided compliance costs throughout that time. | high |
| 02 | The EPA inspection occurred on March 1, 2023, but the settlement was not filed until April 21, 2025. This two-year gap between inspection and final resolution meant the company continued operating during the entire enforcement process. | medium |
| 03 | Frontida submitted its response to the EPA inspection on September 1, 2023, six months after the inspection. This delay extended the period before formal enforcement proceedings began. | low |
| 04 | The EPA did not notify Pennsylvania’s PADEP of the impending enforcement action until October 24, 2024, more than a year and a half after the inspection. This extended timeline delayed potential state-level enforcement or oversight. | medium |
| 01 | A pharmaceutical packaging company violated fundamental environmental protections for years in an urban Philadelphia neighborhood. The violations included operating without permits, skipping required inspections, and mishandling toxic materials. | high |
| 02 | The $13,750 penalty for three years of hazardous waste violations demonstrates the limited financial consequences companies face for environmental non-compliance. Cost savings from avoided compliance may have exceeded penalty costs. | high |
| 03 | No individuals faced accountability despite systematic failures in hazardous waste management. Only the corporate entity paid a penalty, allowing responsible decision-makers to avoid personal consequences. | medium |
| 04 | The case illustrates how regulatory oversight gaps allow violations to persist for years before detection. Three years of weekly inspection failures and undocumented waste shipments went undetected until a 2023 compliance evaluation. | high |
| 05 | The expedited settlement resolved violations efficiently but avoided deeper examination of why a pharmaceutical company owned by a larger corporation systematically failed to follow environmental laws. Questions about corporate culture and priorities remain unaddressed. | medium |
Timeline of Events
Direct Quotes from the Legal Record
“On March 1, 2023, Respondent operated the Facility without a permit by accepting HW from its Orthodox facility, which is a Large Quantity Generator (LQG) of HW. Consolidation of HW by mutually owned facilities is only allowable, with certain exceptions and requirements, by Very Small Quantity Generators to LQGs. Respondent is an SQG that accepted and stored HW from an LQG without a permit.”
๐ก This shows the company knowingly violated permitting rules by accepting hazardous waste it was not authorized to store.
“From March 1, 2020 to at least March 1, 2023, Respondent failed to conduct weekly inspections of its HW accumulation area as required by 25 Pa. Code ยง 262a.10”
๐ก The company skipped mandatory safety inspections for three full years, creating prolonged risk of undetected leaks or releases.
“Facility representatives stated that rejected material is accumulated in the Reject Cage for an unspecified period of time before a HW determination is made. The Inspector observed approximately 200 rejected material containers in the Reject Cage at the time of the Inspection for which a HW determination had not been made.”
๐ก This reveals a systematic failure to determine if materials are hazardous before storage, violating a fundamental requirement of waste management.
“Waste Aerosol Cans โ the Inspector observed in-use aerosol cans at the Facility at the time of the Inspection. The Facility representatives indicated they were unsure how waste aerosol cans are managed by the Facility and unsure how previously generated waste aerosol cans had been disposed.”
๐ก Company representatives admitted they did not know how they manage or dispose of potentially hazardous aerosol cans.
“IPA-contaminated Wipes โ At the time of the Inspection, Facility representatives stated that IPA-contaminated wipes are disposed as nonhazardous waste and did not provide any HW determination documentation for the waste stream.”
๐ก The company disposed of chemical-contaminated wipes without proper testing, risking improper disposal of hazardous materials.
“From March 1, 2020 to at least March 1, 2023, Respondent failed to document HW shipments on Uniform Hazardous Waste Manifests in violation of 25 Pa Code ยง 262a.10 which incorporates by reference 40 C.F.R. ยง 262.20(a)(1). Facility representatives stated that during this time period, HW was shipped from the Facility to the Respondent’s Orthodox facility without documentation on HW manifests.”
๐ก The company admitted to three years of shipping hazardous waste without required tracking documents, eliminating accountability for where waste went.
“At the time of the Inspection, the Inspector observed six (6) open containers of UW lamps in violation of 25 Pa. Code ยง 266b, which incorporates by reference 40 C.F.R. ยง 273.13(d)(1).”
๐ก Open containers of mercury-containing lamps increase breakage risk and potential mercury release, a potent neurotoxin.
“At the time of the Inspection, the Inspector observed six (6) unlabeled containers of UW lamps in violation of 25 Pa. Code ยง 266b, which incorporates by reference 40 C.F.R. ยง 273.14(e).”
๐ก Unlabeled hazardous waste containers prevent proper identification and emergency response if spills or accidents occur.
“At the time of the Inspection, the Inspector observed six (6) containers of UW lamps and two (2) containers of UW batteries that were not marked with start accumulation dates and the Facility did not have another method to track accumulation time, in violation of 25 Pa. Code ยง 266b, which incorporates by reference 40 C.F.R. ยง 273.15(c).”
๐ก Without tracking accumulation time, hazardous materials can be stored longer than legally allowed, increasing deterioration and release risks.
“Complainant and Respondent agree that settlement of this matter for a total penalty of THIRTEEN THOUSAND SEVEN HUNDRED AND FIFTY DOLLARS ($13,750.00) is in the public interest. In calculating this amount, Complainant considered the statutory factors set forth in Section 3008(a)(3) of RCRA, 42 U.S.C. ยง 6928(a)(3), and with specific reference to EPA’s October 1990 RCRA Civil Penalty Policy, as revised in June 2003 (RCRA Penalty Policy), and the 2021 RCRA Expedited Settlement Agreement Pilot.”
๐ก The EPA determined this modest penalty was appropriate despite three years of violations, raising questions about deterrent effectiveness.
“In signing this Agreement, Respondent: admits the jurisdictional allegations in this Agreement; neither admits nor denies the specific factual allegations in this Agreement, except as provided in the jurisdictional admission above”
๐ก The settlement allowed the company to pay a fine without admitting it actually committed the violations described by EPA inspectors.
“By its signature below, Respondent certifies, subject to civil and criminal penalties for making a false submission to the United States Government, that (1) the alleged violations have been corrected, and (2) any documentation or information provided to EPA was true and accurate.”
๐ก The company certified it fixed the problems but faces no documented assessment of harm caused during years of non-compliance.
“EPA reserves the right to commence action against any person, including Respondent, in response to any condition which EPA determines may present an imminent and substantial endangerment to the public health, public welfare, or the environment.”
๐ก The EPA kept authority to take further action if serious environmental or health threats are discovered, suggesting ongoing concerns.
“Late payment of the agreed upon penalty may subject Respondent to interest, administrative costs and late payment penalties in accordance with 40 C.F.R. ยง 13.11.”
๐ก The agreement includes provisions for late payment penalties, but the base penalty itself remains modest relative to the violations.
“agrees to bear its own costs and attorney’s fees; and agrees not to deduct for federal tax purposes the civil penalty assessed in this Consent Agreement and Final Order.”
๐ก The company cannot write off the penalty as a business expense on federal taxes, though the amount is still relatively small.
Frequently Asked Questions
You can read this Expedited Settlement Agreement between the EPA and Frontida (Adare) by visiting the EPA’s website: https://yosemite.epa.gov/OA/RHC/EPAAdmin.nsf/Filings/C65F6629B20A15FB85258C730078F4DF/$File/Frontida%20BioPharm%20LLC_RCRA%20C%20ESA_April%2021%202025.pdf
๐ก Explore Corporate Misconduct by Category
Corporations harm people every day โ from wage theft to pollution. Learn more by exploring key areas of injustice.
- ๐ Product Safety Violations โ When companies risk lives for profit.
- ๐ฟ Environmental Violations โ Pollution, ecological collapse, and unchecked greed.
- ๐ผ Labor Exploitation โ Wage theft, worker abuse, and unsafe conditions.
- ๐ก๏ธ Data Breaches & Privacy Abuses โ Misuse and mishandling of personal information.
- ๐ต Financial Fraud & Corruption โ Lies, scams, and executive impunity.